News

Dr. Tennille Marx, Senior Research Associate at AIBMR Life Sciences, will present "Differences of GRAS Determinations and NDI Notifications" at this year's Vitafoods Europe Conference in Geneva. Dr. Marx will navigate the U.S. regulatory environment with regard to NDIs, the…

An excerpt from the Nutritional Outlook article, written by AIBMR's Drs. Endres and Clewell: "As discussed ahead, FDA’s GRAS self-determination process has had its share of critics. AIBMR hopes that its database plays a role in making information on the…

AIBMR's Dr. John Endres has been selected to present his paper entitled "Getting GRAS Status for Foods & Dietary Supplements in the U.S." to the 16th Annual Vitafoods Europe Conference. Dr. Endres, accompanied by AIBMR staff and co-authors Dr. Amy…

The Council for Responsible Nutrition (CRN) has officially announced AIBMR Life Sciences as an Associate Member. CRN, the leading trade association representing dietary supplement manufacturers and ingredient suppliers, was founded in 1973 and is located in Washington, D.C. For more…

"Small Doses, Big Issues", by AIBMR's Dr. Amy Clewell and Dr. Tennille Marx, is the featured selection in the October issue of Nutritional Outlook magazine. Drs. Clewell and Marx address the unique challenges associated with determining appropriate doses for children's supplements.…

AIBMR's Dr. Alexander Schauss discussed "Risk Assessment of Dietary Supplements and Functional Foods" at the Regional Chapter Meeting of the Pacific Northwest Association of Toxicologists (PANWAT). The full meeting program and list of abstracts, including that of Dr. Schauss, can…

AIBMR is proud to announce that Drs. Alexander Schauss, John Endres, and Amy Clewell have authored a chapter entitled "Safety of Unsaturated Vitamin E Tocotrienols and Their Isomers" in the second edition of the landmark publication Tocotrienols: Vitamin E Beyond Tocopherols.…

"By developing proper SOPs for laboratory qualification, the industry can hopefully work to eliminate this problem altogether", AIBMR's Dr. John Endres notes in his recent article for Nutritional Outlook. Get the full text here: http://bit.ly/PqFgvM

With AIBMR at the research helm, Ganeden Biotech receives "No Objection" letter from the FDA; GanedenBC30 is first Bacillus strain to receive GRAS status. John R. Endres, ND, Chief Scientific Officer, AIBMR Life Sciences, and full member of the Society of…

In her Nutritional Outlook piece, "Ingredient Spotlight: 7-Keto-DHEA, Raspberry Ketones", AIBMR's Dr. Tennille Marx takes a look at dietary ingredients marketed for weight loss. Does the research support the hype? See the research on NutritionalOutlook.com: